Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Bone-Strengthening Drug May Raise Risk of Cancer

September 7, 2010 7:57 am | by Maria Cheng | News | Comments

People who take bone-strengthening drugs for several years may have a slightly higher risk of esophageal cancer, a new study suggests. The findings are in contrast to another recent study that used the same database of 80,000 patients and found no link between the drugs and esophageal cancer.

TOPICS:

WHO Wants Faster Flu Vaccine Production

September 7, 2010 7:54 am | News | Comments

The vaccine used to contain the recent swine flu pandemic was effective, but health authorities will need to ramp up the speed and volume of production during the next global outbreak, a World Health Organization official said.

TOPICS:

Feds Hold Off On ProAmatine Withdrawal

September 7, 2010 7:49 am | News | Comments

Federal regulators have backed off a plan to remove a Shire PLC low blood-pressure treatment from the market after warning in August that the drug has not been proven effective.

TOPICS:
Advertisement

British Regulators Want Avandia Yanked

September 7, 2010 7:36 am | News | Comments

GlaxoSmithKline's controversial diabetes pill Avandia should be pulled from the U.K. market because of concerns that the drug can increase the risk of heart attacks, British drug regulators said.

TOPICS:

Japan Confirms Presence of Superbug Gene

September 7, 2010 7:34 am | by Shino Yuasa | News | Comments

Japan has confirmed the nation's first case of a new gene in bacteria that allows the microorganisms to become drug-resistant superbugs, detected in a man who had medical treatment in India, a Health Ministry official said.

TOPICS:

Multipurpose Filters

September 2, 2010 9:03 am | Product Releases | Comments

Meissner’s Steridyne 50 (PVDF) and Ultradyne 50 (PTFE) are multipurpose 50 mm filters for small volume venting, gas and solvent filtration. The filters are offered with stepped hose barb inlet/outlet connections.

TOPICS:

Mammalian Cell Lines

September 2, 2010 8:59 am | Product Releases | Comments

Sigma Life Science, the biological products and research services business of Sigma-Aldrich Corporation, announced the global release of a pioneering range of engineered mammalian cell lines.

TOPICS:

First Genetically Engineered Rat Derived From ES Cells

September 2, 2010 8:41 am | News | Comments

StemCells, Inc. announced that its technology was recently used by independent researchers to achieve the first genetically engineered rat derived from rat embryonic stem cells.

TOPICS:
Advertisement

MorphoSys And Absynth Sign Collaboration

September 2, 2010 8:33 am | News | Comments

MorphoSys has signed a license and collaboration agreement with UK-based Absynth Biologics, providing access to novel target molecules associated with Staphylococcus aureus infections including MRSA (methicillin-resistant S. aureus).

TOPICS:

Abnormal Weight A Colon Cancer Risk Factor

September 2, 2010 8:28 am | News | Comments

Postmenopausal women diagnosed with colon cancer may be at increased risk of death if they fail to maintain a healthy body weight before cancer diagnosis, according to a study published in a journal of the American Association for Cancer Research.

TOPICS:

NIH Awards Grants for Biomedical Research In Space

September 2, 2010 8:24 am | News | Comments

The National Institutes of Health announced today that it has awarded the first new grants under the Biomedical Research on the International Space Station (BioMed-ISS) initiative, a collaborative effort between NIH and NASA.

TOPICS:

Idera Pharma Entitled to $3.8M From Merck KGaA

September 2, 2010 8:21 am | News | Comments

Idera Pharmaceuticals, Inc. announced that it has achieved a milestone, the initiation of a Phase 1b clinical trial of IMO-2055, under its worldwide licensing and collaboration agreement with Merck KGaA.

TOPICS:

FDA Approves LUMIGAN As First-Line Therapy

September 2, 2010 8:16 am | News | Comments

Allergan, Inc. announced the United States Food and Drug Administration has approved LUMIGAN 0.01% as a first-line therapy indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

TOPICS:

Black Rice Cheaper, Healthier Than Blueberries

September 2, 2010 8:09 am | News | Comments

Health conscious consumers who hesitate at the price of fresh blueberries and blackberries, fruits renowned for high levels of healthful antioxidants, now have an economical alternative, researchers report.

TOPICS:

NIST Develops New Lab-On-A-Chip

September 2, 2010 8:02 am | News | Comments

Researchers at the National Institute of Standards and Technology have demonstrated a microminiaturized device that can make complex viscosity measurements—critical data for a wide variety of fields.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading